Opioid firms face US criminal liability
Monday, December 2, 2019
Significance
Prosecutors seek to expand the reach of a US statute previously applied only to dealers in illegal drugs, to attempt to establish corporate accountability for the crisis that has cost thousands of lives.
Impacts
- These investigations will be independent of the civil liability companies face; parties will likely settle the myriad civil lawsuits.
- Uncertainty over how to value claims complicates settlement negotiations.
- Punishing opioids manufacturers and distributors could make firms risk-averse, thereby limiting patients’ access to pain relief.